Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ADVENZYMES Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Moderate revenue growth but lower than median growth of industry
Neutral
Moderate and stable ROE
High operating margin but declining trend
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ADVENZYMES Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ADVENZYMES Bulk, Block & Insider Trades
ADVENZYMES Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Stock split(1 : 5)Nominal Value changed from INR 10 to INR 2. Ex-date: 25th May 2017 Announced on: 14th Feb 2017
Company Profile
Advanced Enzyme Technologies Limited is an India-based company engaged in the manufacturing of enzymes and probiotics. It is focused on the research and development, manufacturing, and marketing of approximately 400 products, developed from over 68 enzymes and probiotics. It operates in a business s... Read More
Key personnel
Mr. Vasant Laxminaray RathiD
Non-Executive Chairman of the Board
Mr. Beni Prasad Rauka
Chief Financial Officer
Mr. Dipak Roda
Senior Vice President - Business Development, Marketing
Mr. Mukund Madhusudan KabraD
Whole Time Director
Ms. Martina Doering
Managing Director and Head Of Business Development, Evoxx Technologies GmbH, Germany
Mr. Harshad Doshi
Chief Financial Officer and Chief Operating Officer of the US Subsidiaries
Dr. Michael Puls
Managing Director and Head Of Research and Development, Evoxx Technologies GmbH, Germany
Mr. Sanjay Basantani
Company Secretary and Head Legal
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Advanced Enzyme Technologies Ltd.?
The current share price of Advanced Enzyme Technologies Ltd. is ₹ 302.60 as of 09 Jan 2026.
What is the PE ratio of Advanced Enzyme Technologies Ltd.?
The Price-to-Earnings (PE) ratio of Advanced Enzyme Technologies Ltd. is 22.98 as of the latest financial data.
What is the ROE and ROCE of Advanced Enzyme Technologies Ltd.?
Advanced Enzyme Technologies Ltd. has a Return on Equity (ROE) of 10.43% and a Return on Capital Employed (ROCE) of 11.89% as per the latest financial reports.
What is the market cap of Advanced Enzyme Technologies Ltd.?
The market capitalization of Advanced Enzyme Technologies Ltd. stands at ₹ 3,386.91 Cr.
What is the dividend yield of Advanced Enzyme Technologies Ltd.?
The dividend yield of Advanced Enzyme Technologies Ltd. is 1.72% based on the current market price.
What is the RSI of Advanced Enzyme Technologies Ltd.?
The Relative Strength Index (RSI) of Advanced Enzyme Technologies Ltd. is 46.81.
What is the FII and DII holding in Advanced Enzyme Technologies Ltd.?
Foreign Institutional Investors (FII) hold 25.41% and Domestic Institutional Investors (DII) hold 3.24% of Advanced Enzyme Technologies Ltd. shares.
What sector does Advanced Enzyme Technologies Ltd. belong to?
Advanced Enzyme Technologies Ltd. operates in the Healthcare sector.
What is the beta of Advanced Enzyme Technologies Ltd. stock?
The beta of Advanced Enzyme Technologies Ltd. stock is 0.96, indicating its volatility relative to the broader market.
